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Abstract
Background: We aimed to evaluate the effect of an 8-week yoga intervention on the shoulder and spinal actions
of women with breast cancer-related arm lymphoedema.
Method: A randomised controlled pilot trial. The intervention group (n = 12) completed eight weeks of daily yoga
sessions while the control group (n = 11) continued with best current care including information on compression
sleeves, skin care, risks of temperature variations and recommended safe use of affected arm. Lumbo-pelvic posture,
range of motion (ROM) in the shoulder and spine, and strength in shoulder and pectoral major and minor, and serratus
anterior were taken at baseline, week 8 and after a 4-week follow-up. Outcome assessors were blinded to allocation.
Results: At week eight the intervention group had an improvement in lumbo-pelvic posture, as indicated by
a reduction in pelvic obliquity compared to the control group (mean difference = −8.39°, 95 % CI: −15.64 to
−1.13°, p = 0.023). A secondary finding was that strength in shoulder abduction significantly increased
following the yoga intervention in both the affected (9.5 kg; CI: 0.34 to 18.66, p = 0.042) and non-affected arm
(11.58 kg; CI: 0.25 to 22.91; p = 0.045). There were no significant between group changes in any ROM
measures as a result of the yoga intervention.
Conclusion: This pilot study demonstrates that participation in yoga may provide benefits for posture and
strength in women with Breast Cancer Related Lymphoedema. The improvements may be attributed to the
focus of yoga on overall postural and functional movement patterns. Further trials with longer intervention
that follow this methodology are warranted.
Trial registration: The Australian New Zealand Clinical Trials Registry ACTRN12611000202965.
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Background
In spite of improvements to surgery and radiation treat-
ment, breast cancer-related lymphoedema (BCRL) con-
tinues to affect at least 20 % of women undergoing
breast cancer treatment with axillary clearance [1]. As a
chronic condition, lymphoedema requires life-long man-
agement to prevent the condition worsening and occur-
rence of infections such as cellulitis [2].
Upper body impairment is common in women with
BCRL, whose reduction in functional activity can be
higher than in women who have had breast cancer treat-
ment without lymphoedema [3]. Impairment of the af-
fected arm is evident in loss of shoulder range of motion
(ROM) and strength [4] and changed bio-mechanics of
the shoulder girdle, all leading to loss of symmetry be-
tween sides [5, 6]. These constraints produce difficulty
with daily activities including household chores, driving,
hobbies, carrying items and activities which require fine
motor coordination of the hand [7]. Limitation of activ-
ity and level of pain have been associated with lower
quality of life (QOL) [8]. Exercise interventions for
women with BCRL have resulted in increased shoulder
ROM [9], strength [10] and improved QOL [9], indicat-
ing that physical therapies may improve upper body
morbidity [11].
Yoga is an integrated system that consists of breathing
(pranayama), postures (asana), meditation and relaxation
designed to improve the biopsychosocial functioning of
an individual, irrespective of their limitations [12]. Im-
provements in physical flexibility, strength, neuro-motor
coordination and postural alignment in a range of popu-
lations have been reported [13]. For this reason, yoga
has been recommended as an adjunct to physiotherapy
in a rehabilitation setting [14] including for those with
lymphoedema [15] and may assist in correcting the
upper body impairment frequently experienced by
women with BCRL. However, currently the authors are
unaware of any published research on the effect of yoga
on posture, shoulder and spinal ROM and shoulder
strength in women with BCRL.
The objective of this pilot trial was to obtain prelimin-
ary data to evaluate the effects of an 8-week yoga inter-
vention on the upper body of women with stage one
BCRL. This paper reports on outcomes of postural align-
ment, ROM of the shoulder and spine, and strength of
the shoulder and other muscles affected by breast cancer
surgery and treatment, i.e. pectoralis major, pectoralis
minor and serratus anterior.
Methods
Study design
The trial was a multicentre parallel randomised controlled
pilot trial (RCT) (Australian New Zealand Clinical Trials
Registration ACTRN12611000202965). Ethics approval
was granted by University of Tasmania Social Sciences
Human Research Ethics Committee (H00011534).
The study was part of a larger study. The full protocol
has been described previously [16] and the primary out-
comes for the effects of yoga on lymphoedema and its
sequelae and QOL have been published [17]. This manu-
script presents the results for the secondary outcome
measures of shoulder and spinal ROM and shoulder
strength. Outcome measurements were performed at
baseline, week 8 (on completion of intervention) and at
week 12 (one month after intervention). Group alloca-
tion was conducted by a person independent of the trial
using a computer-generated random number system on
a 1:1 allocation ratio to intervention or control group.
Notification of group allocation in sequentially num-
bered opaque sealed envelopes occurred after the base-
line measurements. None of the assessors were involved
in either the allocation or the delivery of the interven-
tion. Participants were asked not to divulge their treat-
ment to assessors and assessors did not have access to
previous results.
Sample size calculation
A preliminary sample size calculation indicated that to
detect a clinically significant increase in shoulder ROM
of at least 10° between the two groups with expected
within-group-differences of 10 % of the mean with 80 %
power, so that 13–18 participants would be required for
each group.
Participants
Women were eligible for inclusion if they had unilateral
secondary lymphoedema of the arm, stage one as de-
fined by the International Society of Lymphology [18],
confirmed by a professional lymphoedema therapist, had
completed treatment for breast cancer (surgery, radio-
therapy and chemotherapy) at least six months previ-
ously, were over 18 years and had sufficient English
language comprehension to provide informed consent
and understand yoga instruction. Women were advised
that no new exercise should be commenced during the
trial. Women were excluded if they had recurrent cancer,
an infection or were having Complex Lymphoedema
Therapy, if they were pregnant, wore a pacemaker, which
would affect bioimpedance (BIS) readings, had severe
psychological illness or were currently doing yoga.
Women’s safety being paramount, it was thought that in-
cluding only stage one BCRL may reduce the chance of
a flare-up of lymphoedema occurring. The trial was ad-
vertised on local radio and in local newspapers, with
lymphoedema therapists and breast care nurses through-
out Tasmania and on community and health related
noticeboards.
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A manual containing information on best current care
for BCRL was given to all participants at the commence-
ment of the trial on the instructions of the overseeing
ethics committee. Recommended current care included
information on wearing of professionally fitted compres-
sion sleeve and when to wear it, continuing recom-
mended skin care and avoiding cuts to the skin and
extreme temperatures, wearing non-restrictive clothing,
maintaining a healthy weight, and using the affected arm
without undue strain such as repeating the same move-
ment or holding the arm in one position for a long
period of time. Women were advised to continue any
current exercise, but not to commence any new activity
during the trial period, and to seek immediate medical
help in the event of an exacerbation of lymphoedema
during the trial. Compliance to this request was mea-
sured using the International Physical Activity Question-
naire (IPAQ), a reliable measure of activity in this
population [19] in the week prior to each measurement
period. Daily physical activity was measured using a VAS
scale as previously described [16].
Control group
As lymphoedema is a medical condition that will worsen
without treatment, participants randomised to the con-
trol group were requested to maintain their usual self-
care throughout the trial period and were offered the
same 8-week teacher led yoga with home-practice DVD
as the intervention group at the completion of the final
measurement.
Yoga intervention group
The intervention consisted of a weekly 90-min teacher-
led yoga class and a daily 45-min home-practice yoga
session provided by DVD in addition to their usual self-
care. Participants recorded their daily practice along
with any relevant comments in a personal logbook.
Women had the choice of wearing their compression
sleeve during each session, as long as the compression
sleeve was worn immediately on completion of each
yoga session [20].
The Satyananda Yoga® style [21] was chosen as its sys-
tematised and progressive practices are based on an inte-
grated system consisting of pranayama, asana, meditation
and relaxation with options for modifications. The prac-
tices were chosen following the principles of manual
lymphatic drainage [22], with gentle ROM actions of the
shoulder and spine focussing on posture and kinematic
movement patterns while engaging core and shoulder-
stabilising muscles, and stress reduction. Safety precau-
tions and exercise guidelines for women with BCRL were
adhered to [23]. A full rationale [24] and basic outline of
the yoga program [17] for the yoga group has been de-
scribed previously.
Outcome measurements
Anthropometric measurements were conducted and
followed by shoulder ROM and strength tests with the
same trained assessor at each time-point. A sub-group
of women (n = 15), who volunteered for spinal ROM
were tested on the day following other measurements.
Participants were asked to volunteer separately for this
assessment due to the need to partially undress for as-
sessment, and were assured of the privacy they would be
given.
Range of motion of shoulder
Active shoulder ROM was measured according to an
established reliable and validated method [25] using a
two-armed goniometer [26]. Briefly, participants sat in a
low-back chair with stable shoulder blades and suitable
back support, their knees bent to 90° and their feet at
hip width and flat on the floor. Flexion, abduction and
extension of the shoulder in the sagittal or coronal
planes were measured with the arms in anatomical pos-
ition. Internal and external rotation of the shoulder were
measured from the starting position of the arm abducted
to 90°, forearm pronated and parallel to the floor, palm
down, with elbow bent to 90°. To prevent fatigue of the
affected arm, measuring was conducted in the following
order: flexion, internal rotation, extension, abduction,
external rotation. The endpoint of measurement was full
range, compensatory movements of the shoulder or
trunk occurring, or participant experiencing pain or
tightness. The final score was recorded in degrees as the
best of three attempts [25].
Strength of shoulder and pectoralis major, pectoralis
minor and serratus anterior
Muscle strength was measured according to an estab-
lished protocol [27] using a reliable and valid handheld
dynamometer (Commander Powertrack II Muscle
Tester; JTechMedical, Salt Lake City, Utah, USA) [28].
The participant sat in a stable position and the non-
affected, then the affected, arm was measured in turn,
three times for each action. The arm was raised to 90°
for the strength measurements of flexion, horizontal ad-
duction and abduction. To measure the strength in ex-
tension, the participant’s arm was by her side. The arm
was positioned slightly across the body for the strength
measurement of the pectoralis major and the arm ele-
vated to 120° for the serratus anterior. The strength of
pectoralis minor was measured with the participant in
supine position. This was also the order of measuring
used to prevent fatigue.
The strength of the shoulder/separate muscles (pector-
alis major, pectoralis minor, serratus anterior) was mea-
sured from the force applied against the resisted hand-
held dynamometer, held by the assessor, for a count of
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three seconds. Measurement ceased when full strength
was applied, compensatory movements of the shoulder
or trunk occurred or pain was experienced. The best of
three attempts was recorded in Newtons (N).
Grip strength
Hand grip strength was assessed using a hand-held grip
dynamometer (Smedleys, TTM, www.stoeltingco.com),
validated for use in a clinical setting [29], as previously
described [16].
Spinal mobility
Spinal mobility was measured dynamically using video
analysis in order to quantify the functional mobility of
the spine during lateral flexion and flexion/extension
from a stable standing position and thoracic spinal rota-
tion in a stable sitting position according to established
protocols [30]. Each movement was performed three
times in a slow controlled fashion with no break be-
tween repetitions.
Movements were recorded by a video camera with back-
lighting, utilising reflective surface markers placed on par-
ticipants’ skin at the following locations: left and right
posterior superior iliac spines (LPSI, RPSI), spinal pro-
cesses (S1, L3, L1, T6, T1) and left and right acromion
(LACR, RACR). Reflective markers were also placed on
the wall and floor for calibration. At the initial measure-
ments, the distance between markers applied to the par-
ticipant’s skin was recorded to ensure consistency.
Video data was analysed using Quintic™ Sports Bio-
mechanics Video Analysis Software (9.03 version 14;
Quintic Consultancy Limited; www.quintic.com). Mea-
surements were made of the position of each marker in
the reference plane from resting position to range in
each direction. This allowed calculation of the angles in
degrees defined in Table 1, following methods described
elsewhere [30]. The range of excursion of each angle was
recorded, except for pelvic obliquity and angle of ky-
phosis at rest which were static angles.
Data analysis
Baseline information for demographic and medical char-
acteristics between treatment groups were compared by
independent two-tailed t-tests for continuous variables
and by Yates corrected chi-square tests for categorical
variables (SPSS version 19; IBM, Armonk, New York,
USA). Statistical analyses of outcome measures at base-
line and changes between groups at weeks 8 and 12 were
performed using STATA statistical software (version 12;
STATA Corporation, College Station, Texas, USA). Para-
metric longitudinal data were analysed via mixed
methods linear regression (ANOVA). Where assump-
tions of linear regression were violated, data were ana-
lysed using non-parametric analysis via ordinal logistic
regression. Post-hoc testing was performed on all data
using the Holms test to locate the means that were sig-
nificantly different. Statistical significance was set at p <
0.05. Due to the low sample size neither multivariate nor
Table 1 Relationship between markers and angles for spinal mobility
Abbreviation Action Definition
Lateral Flexion
β1 Pelvic obliquity at rest Angle at rest between the pelvic axis (the vector LPSI-RPSI) and the horizontal plane.
β2 Lumbar lateral flexion
range
Angle between S1-L1 vector and the vertical pelvic axis through full range of lateral flexion.
β3 Thoracic lateral flexion
range
Angle between the T1-L1 vector and S1-L1 vector through full range of lateral flexion.
β4 Shoulder range Angle between the vector connecting both shoulders with the horizontal plane through full range of lateral
flexion.
βdc Thoracic distal curvature
range
Angle between vectors S1-L3 and L3-T6 through full range of lateral flexion.
βpc Thoracic proximal
curvature range
Angle between vectors L3-T6 and T6-T1 through full range of lateral flexion.
βlti Full lateral trunk
inclination range
Angle between the S1-T1 vector and the vertical axis through full range of lateral flexion.
Flexion-Extension/Rotation
αkrest Angle of thoracic
kyphosis at rest
Angle at rest between the vectors L3 –T6 and T6-T1.
α3 Thoracic range Angle between the vector T1-L1 and the vector S1-L1 through the full range of flexion/extension.
αfti Full trunk flexion/
extension range
Angle between the S1-T1 vector and the vertical axis in flexion/extension.
Tr Thoracic spinal rotation
range
Angle between the vector from the line of the shoulders (LACR – RACR) and the vector defined by the line
of the hips (LPSI - RPSI) throughout the full range of thoracic spinal rotation.
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covariate analyses were performed. Data is presented as
Mean (M) and Standard Deviation (SD) unless otherwise
indicated.
Results
Participant flow through the trial is presented in Fig. 1.
From 59 potential participants who expressed an interest
in the study, 28 consented and underwent baseline test-
ing with 15 randomised to the yoga intervention and 13
to the usual care control.
Compliance with the intervention
Two participants withdrew after being diagnosed with
recurrent cancer during the trial while seven others ex-
perienced adverse events requiring their withdrawal
from the study that were unrelated to either their condi-
tion or the treatment. Briefly, five participants withdrew
due to adverse events unrelated to the yoga intervention
during the eight-week intervention period while another
four withdrew between the end of the intervention and
the follow up measurement (Fig. 1).
Due to these events, fewer participants returned for
the week-12 follow-up than completed the week 8 mea-
surements. Consequently, the results from baseline to
end of the 8 week intervention (b-8) and end of the
week 8 intervention to week 12 follow-up (8b-12) were
analysed separately.
Apart from that prescribed for the intervention group,
during the trial, no women in either group were doing
yoga, nor had they done it since developing BCRL.
Fig. 1 Flow of the trial
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Attendance at the yoga sessions was high (97 %), as was
self-reported compliance with the home-practice DVD
(86 %). There were no statistically significant changes in
physical activity by either group across all time points as
measured by either the IPAQ questionnaire or VAS
scale.
Characteristics of the group
There were no demographic or medical differences from
diagnosis and treatment for breast cancer and lymphoe-
dema in the groups at baseline (Table 2). Twenty-three
participants, with a mean age of 57.6 ± 10.5 years (range
34–80) and a mean BMI of 27.2 ± 4.9 kg/m2 (range
20.4–37.3), completed the eight week intervention and
19 women returned for the week 12 follow-up
measurement.
Outcomes
BMI
At baseline, the intervention group had a higher BMI
(Mean Difference (MD) 4.03 kg; 95 % Confidence Inter-
vals (CI): 0.24 to 7.81; p = 0.023) than the control group.
However, at week 8 (MD −0.6 kg; 95 % CI: −1.98 to
−0.01; p = 0.147) and at week 12 (MD −0.41 kg; 95 % CI:
−1 to 0.187; p = 0.378) this difference was not significant.
Due to the low numbers in the trial no correlation ana-
lysis was carried out for the BMI baseline measurement.
Shoulder ROM
At baseline there was an inhibited ROM in all shoulder
ROM measures across both groups with the affected
arm exhibiting non-significant reduced ROM compared
to the affected arm. There were no statistically signifi-
cant differences in shoulder ROM between groups at
baseline. From b-8, there was a difference in the change
between groups in abduction (MD −14.70°; 95 % CI:
−29.30 to −0.10; p = 0.049) and flexion (MD −19.00°;
95 % CI: −33.65 to −4.36; p = 0.011) of the non-affected
arm due to the increase in abduction (MD 10.7°; 95 %
CI:-0.08 to 21.48; p = 0.052) and flexion (MD 20.5°; 95 %
CI: 9.68 to 31.32; p = 0.001) in the control group and lit-
tle change in the intervention group (Table 3). Each
group had significant changes for other actions
(Table 3).
From 8b-12, the intervention group demonstrated de-
creased internal rotation of the affected arm compared
to the control group (MD −10.97°; 95 % CI: −17.37 to
−4.56; p = 0.001) due to the decrease in the intervention
group (MD −6.67°; 95 % CI: −11.31 to −2.02; p = 0.005)
and the increase in the control group (MD 4.3°; 95 % CI:
−0.11 to 8.78; p = 0.056). Results for shoulder ROM are
presented in Table 3.
Shoulder strength
There were no differences between groups in actions of
shoulder strength at baseline. From b-8 and 8b-12, there
were no significant changes between groups. However,
from b-8, abduction of both the affected (MD 9.5 kg;
95 % CI: 0.34 to 18.66; p = 0.042) and the non-affected
(MD 11.58 kg; 95 % CI: 0.25 to 22.91; p = 0.045) shoul-
der increased in the intervention group (Table 4).
Strength of pectoralis major, pectoralis minor and serratus
anterior
There were no differences between groups in strength
actions for these muscles at baseline. From b-8, there
were no changes between groups. From 8b-12, there was
a decrease in the strength of the non-affected pectoralis
major in the intervention compared to the control group
(MD −11.80 N; 95 % CI: −19.21 to −4.38; p = 0.002) due
to the decrease in the intervention group (MD −7.88 N;
95%CI −13.27 to −2.50; p = 0.004). Both groups had sig-
nificant increases for serratus anterior at week 8 and sig-
nificant decreases for pectoralis minor at week 12
(Table 4).
Grip strength
There were no differences between groups in grip
strength at baseline or from b-8. From 8b-12 there was a
decrease in grip strength of the affected arm (MD
3.58 kg; 95 % CI:1.50 to 5.67; p = 0.01) due to the de-
crease in the control group (MD −3.25 kg; 95 % CI
−4.69 to −1.82; p = 0.002) (Table 4).
Spinal mobility
At baseline, the intervention group had a higher (worse)
angle of pelvic obliquity compared to the control group
(MD +9.97°; 95 % CI: 2.76 to 17.17; p = 0.007). From b-8,
the angle of pelvic obliquity was lower (improved) in the
intervention group compared to the control group (MD
−8.39°; 95 % CI: −15.64 to −1.13; p = 0.023) due to the
reduction in pelvic obliquity in the intervention group
(MD −9.96°; CI: −14.54 to −5.37; p = 0.001).
At baseline, the angle of thoracic kyphosis at rest was
higher (worse) in the intervention group (MD 8.13°; 95 %
CI: −0.10 to 16.37; p = 0.053). From b-8, there was a ten-
dency towards reduction (improvement) for the angle of
kyphosis in the intervention group compared to the con-
trol group (MD −3.88°; 95 % CI −8.08 to 0.32; p = 0.070).
No between-group changes from b-8 or 8b-12 were
observed for any other measure of spinal mobility
(Table 5).
Discussion
To the best of our knowledge this was the first study to
examine the effects of a yoga intervention on shoulder
and spinal ROM and shoulder strength in women with
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Table 2 Participants baseline and medical characteristics of the groups
Characteristic Intervention (n = 12) Control (n = 11) P valuea
Age (years; Mean ± SD) 55.1 ± 2.5 60.5 ± 3.6 0.230
Range 36–65 34–80
Number nodes removed (Mean ± SD) 14.3 ± 2.6 11.2 ± 2.7 0.429
Range 5–30 2–25
How long lymphoedema (years; Mean ± SD) 4.9 ± 1.6 5.5 ± 1.9 0.900
Range 6 months–20 years 1 month–23 years
How long post-surgery (years; Mean ± SD) 1.2 ± 0.4 1.9 ± 0.7 0.822
Range 1 month–5 years 1 month–8 years
n % n % P valueb
Occupation
Home, retired 5 (42) 8 (73) 0.280
Employed 7 (58) 3 (27)
Fitness (self-scored)
Low 2 (17) 1 (9)
Medium 8 (67) 8 (73) 0.913
High 2 (17) 2 (18)
Most significant exercise
Walking 8 (67) 8 (73) 0.890
Gardening 7 (58) 7 (64) 0.867
Gym - organised exercise 1 (8) 8 (73) 0.006
Type of surgery
Lumpectomy 5 (42) 3 (27)
Mastectomy 7 (58) 8 (73) 0.882
Type of lymph dissection
Sentinel node 0 1 (9)
Axillary clearance 12 (75) 10 (73) 0.980
Stage of breast cancer
Ductal Carcinoma In Situ (DCIS) 0 1 (9)
1 3 (25) 4 (36)
2 6 (50) 5 (45) 0.976
3 3 (25) 1 (9)
Treatment
Chemotherapy 8 (66) 6 (54) 0.867
Radiotherapy 9 (75) 7 (64) 0.890
Most common area of radiotherapy
Chest 7 (58) 7 (64)
Axilla 2 (17) 2 (18) 0.909
Axilla and chest 3 (25) 2 (18)
Lymphoedema dominant/non-dominant
Dominant 7 (58) 7 (64) 0.867
Non-dominant 5 (42) 4 (36)
*P < 0.05
a P values obtained using two-tailed independent samples t-test
b P values obtained using chi-square test with Yates correction
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Table 3 Results shoulder ROM b-8 and 8b-12
Within group changes b-8 Between group changes b-8 Within group changes 8b-12 Between group changes 8b-12
VariableGp (n) Week 0
m ± SD
Week 8
m ± SD
P (0–8) Δint-Δcon 0–8
Md; (95 % CI)
P (0–8) VariableGp (n) Week 8b
m ± SD
Week 12
m ± SD
P (8b) Δint-Δcon 8b-12
Md; (95 % CI)
P (8b-12)
Abduction affected
Con(11) 91.82 ± 19.46 105.00 ± 14.01 0.008 −5.43;(−18.95 to 8.08) 0.431 Con(10) 104.40 ± 14.62 108.30 ± 16.49 0.344 −4.90; (−16.64 to 6.84) 0.413
Int(12) 88.17 ± 16.45 95.92 ± 15.70 0.104 Int(9) 92.56 ± 16.48 91.56 ± 10.25 0.818
Abduction non-affected
Con(10) 100.00 ± 18.45 110.70 ± 14.36 0.052 −14.70;(−29.30 to −0.10) 0.049 Con(9) 109.44 ± 14.64 114.22 ± 12.37 0.305 −3.00; (−15.92 to 9.92) 0.649
Int(12) 101.58 ± 17.75 97.58 ± 16.19 0.426 Int(9) 93.00 ± 16.17 94.78 ± 8.03 0.703
Flexion affected
Con(11) 101.82 ± 17.31 121.18 ± 16.89 0.001 −7.45;(−19.45 to 4.65) 0.228 Con(10) 119.80 ± 17.14 122.50 ± 16.96 0.530 −1.37; (13.61 to 10.87) 0.827
Int(12) 103.75 ± 12.47 115.67 ± 12.49 0.005 Int(9) 112.22 ± 12.62 113.56 ± 13.87 0.769
Flexion non-affected
Con(10) 106.10 ± 13.80 126.60 ± 13.37 0.001 −19.00;(−33.65 to −4.36) 0.011 Con(9) 125.33 ± 13.53 126.44 ± 16.68 0.847 4.89; (−11.12 to 20.89) 0.549
Int(12) 110.08 ± 10.23 111.58 ± 15.66 0.766 Int(9) 106.89 ± 15.26 112.89 ± 15.50 0.299
Internal rotation affected
Con(11) 47.18 ± 20.24 52.82 ± 18.76 0.526a 6.86;(7.20 to 20.92) 0.448a Con(10) 52.70 ± 19.77 57.00 ± 19.43 0.056 −10.97;(−17.37 to −4.56) 0.001
Int(12) 45.83 ± 14.53 58.33 ± 11.51 0.050a Int(9) 58.78 ± 11.44 52.11 ± 13.08 0.005
Internal rotation non-affected
Con(10) 47.40 ± 10.43 59.30 ± 13.12 0.031 −6.15;(−20.80 to 8.52) 0.411 Con(9) 59.22 ± 13.91 55.11 ± 15.07 0.316 1.67; (−9.71 to 13.04) 0.774
Int(12) 53.00 ± 17.49 58.75 ± 14.72 0.255 Int(9) 59.00 ± 15.98 56.56 ± 11.78 0.551
Extension affected
Con(11) 38.36 ± 9.29 48.27 ± 8.92 0.030 −0.41;(−9.41 to 8.59) 0.929 Con(10) 48.20 ± 9.40 51.60 ± 7.81 0.147 −5.96; (−12.64 to 0.73) 0.081
Int(12) 35.42 ± 11.45 44.92 ± 11.65 0.003 Int(9) 42.33 ± 12.21 39.78 ± 10.65 0.302
Extension non-affected
Con(10) 39.50 ± 9.25 48.30 ± 4.45 0.005a 3.03;(−6.12 to 12.18) 0.768a Con(9) 47.89 ± 4.51 51.78 ± 7.26 0.120 −6.33; (−13.27 to 0.60) 0.073
Int (12) 37.42 ± 12.10 49.25 ± 11.69 0.021a Int(9) 48.89 ± 13.37 46.44 ± 11.22 0.328
External rotation affected
Con(11) 65.54 ± 11.89 71.00 ± 6.29 0.041a −2.20;(−12.34 to 7.95) 0.360a Con(10) 70.30 ± 6.17 72.50 ± 6.65 0.282 −4.20; (−10.02 to 1.62) 0.157
Int(12) 63.33 ± 20.28 66.50 ± 11.12 0.945a Int(9) 64.56 ± 12.20 62.56 ± 9.83 0.353
External rotation non-affected
Con(10) 70.50 ± 14.30 71.60 ± 14.20 0.702 −2.35;(−9.98 to 5.28) 0.546 Con(9) 70.89 ± 14.87 72.44 ± 13.69 0.353 0.89; (−3.76 to 5.53) 0.708
Int(12) 69.08 ± 12.32 67.83 ± 12.10 0.634 Int(9) 63.67 ± 10.28 66.11 ± 11.25 0.145
Δ = change, Gp Group, M± SD Mean ± Standard Deviation, MD Mean Difference, CI Confidence Interval, n number, Con control group, Int intervention group
a non-parametric analysis
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Table 4 Results strength b-8 and 8b-12
Within group changes b-8 Between group changes b-8 Within group changes 8b-12 Between group changes 8b-12
Variable
Gp (n)
Week 0
m ± SD
Week 8
m ± SD
P (0–8) P(0) Δint-Δcon 0–8
Md; (95 % CI)
P(0–8) Variable
Gp (n)
Week 8b
m ± SD
Week 12
m ± SD
P (8b-12) Δint-Δcon 8b-12
Md; (95 % CI)
P(8b-12)
SHOULDER STRENGTH
Abduction affected
Con(11) 66.69 ± 27.75 71.11 ± 22.16 0.365 0.327 5.08; (−8.16 to 18.33) 0.452 Con(10) 71.18 ± 23.36 64.42 ± 21.17 0.074 2.89; (−7.88 to 13.67) 0.599
Int(12) 56.83 ± 23.26 66.33 ± 22.82 0.042 Int(9) 64.49 ± 23.54 60.62 ± 31.69 0.332
Abduction non-affected
Con(10) 71.82 ± 28.95 75.24 ± 21.77 0.573 0.246 8.16; (−8.26 to 24.58) 0.330 Con(9) 75.29 ± 23.09 70.09 ± 19.62 0.220 −1.20; (13.28 to 10.88) 0.846
Int(11) 59.18 ± 23.76 70.76 ± 26.07 0.045 Int(9) 68.75 ± 26.45 61.02 ± 22.61 0.153
Flexion affected
Con(11) 73.13 ± 24.33 78.51 ± 29.09 0.298 0.777 −2.83; (−16.86 to 11.20) 0.692 Con(10) 79.10 ± 30.60 76.04 ± 30.64 0.506 −0.56; (−13.67 to 12.54) 0.933
Int(12) 70.17 ± 24.20 72.72 ± 24.34 0.606 Int(9) 71.53 ± 26.62 67.91 ± 27.82 0.455
Flexion non-affected
Con(10) 69.04 ± 24.44 79.78 ± 28.66 0.071 0.964 −5.54; (−21.63 to 10.55) 0.500 Con(9) 81.07 ± 30.09 83.91 ± 30.38 0.525 −8.53; (−21.31 to 4.25) 0.191
Int(11) 68.53 ± 30.45 73.73 ± 25.17 0.359 Int(9) 74.98 ± 26.73 69.84 ± 31.86 0.230
Extension affected
Con(11) 93.44 ± 18.33 82.51 ± 31.07 0.098 0.293 −0.59; (−18.53 to 17.35) 0.949 Con(10) 83.06 ± 32.69 79.52 ± 26.76 0.504 −3.82; (−18.89 to 11.26) 0.620
Int(12) 81.85 ± 30.26 70.33 ± 29.12 0.069 Int(9) 64.51 ± 27.04 57.16 ± 25.52 0.187
Extension non-affected
Con (10) 88.72 ± 20.82 87.84 ± 29.56 0.902 0.329 −8.94; (−28.25 to 10.37) 0.364 Con(9) 86.60 ± 31.08 87.64 ± 32.16 0.833 −3.90; (−18.03 to 10.23) 0.588
Int (11) 78.58 ± 26.33 68.76 ± 20.62 0.149 Int(9) 67.33 ± 20.67 65.69 ± 28.97 0.585
Horizontal adduction affected
Con (11) 58.00 ± 19.86 60.80 ± 15.41 0.485 0.744 −1.88; (−12.77 to 9.00) 0.734 Con(10) 60.06 ± 16.04 58.52 ± 20.06 0.644 −4.82; (−14.32 to 4.69) 0.321
Int(12) 55.73 ± 18.56 56.65 ± 13.60 0.811 Int(9) 54.02 ± 13.21 47.67 ± 8.23 0.071
Horizontal adduction non-affected
Con(10) 59.60 ± 21.42 63.80 ± 13.44 0.356 0.851 −7.40; (−19.72 to 4.92) 0.239 Con(9) 63.56 ± 14.23 66.47 ± 18.32 0.376 −8.54; (−17.90 to 0.84) 0.074
Int(11) 58.20 ± 19.24 55.00 ± 14.82 0.461 Int(9) 53.90 ± 13.04 47.91 ± 9.12 0.105
SEPARATE MUSCLES
Pectoralis major affected
Con(11) 53.99 ± 18.91 53.40 ± 14.36 0.891 0.918 −2.16; (−13.82 to 9.50) 0.717 Con(10) 52.80 ± 14.99 50.38 ± 11.52 0.327 −0.02; (−7.05 to 7.00) 0.995
Int(12) 54.82 ± 21.97 52.07 ± 17.05 0.504 Int(9) 50.60 ± 16.24 48.16 ± 13.85 0.347
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Table 4 Results strength b-8 and 8b-12 (Continued)
Pectoralis major non-affected
Con(10) 55.00 ± 18.26 57.20 ± 14.67 0.549 0.679 −4.60; (−14.52 to 5.33) 0.364 Con(9) 54.76 ± 13.22 58.67 ± 15.12 0.133 −11.80; (−19.21 to −4.38) 0.002
Int(11) 58.40 ± 21.63 56.00 ± 19.04 0.493 Int(9) 54.45 ± 18.70 47.18 ± 15.01 0.004
Pectoralis minor affected
Con(11) 25.80 ± 6.89 28.80 ± 4.77 0.101 0.611 −0.98; (−5.95 to 3.98) 0.698 Con(10) 29.48 ± 4.42 22.44 ± 2.27 0.001 0.44; (−2.73 to 3.61) 0.786
Int(12) 26.95 ± 5.79 28.97 ± 4.48 0.250 Int(9) 29.33 ± 3.97 22.73 ± 4.92 0.001
Pectoralis minor non-affected
Con(11) 27.40 ± 8.93 29.20 ± 6.82 0.495 0.898 −0.80; (−8.11 to 6.51) 0.830 Con(10) 29.26 ± 7.19 22.22 ± 5.33 0.002 1.46; (−5.11 to 8.03) 0.663
Int(11) 27.00 ± 8.81 28.00 ± 7.24 0.705 Int(9) 28.60 ± 7.98 22.98 ± 4.68 0.024
Serratus Anterior affected
Con(11) 37.77 ± 7.02 46.00 ± 15.16 0.059 0.657 1.09; (−9.93 to 12.10) 0.847 Con(10) 45.32 ± 15.80 46.20 ± 16.17 0.168a −3.32; (−13.91 to 7.26) 0.264a
Int(12) 35.86 ± 13.88 44.18 ± 12.18 0.008 Int(9) 47.44 ± 10.58 44.00 ± 10.08 0.593a
Serratus Anterior non-affected
Con(10) 33.00 ± 7.89 49.94 ± 13.24 0.001 0.981 −4.28; (−11.46 to 2.90) 0.243 Con(9) 50.36 ± 13.98 45.78 ± 15.59 0.190 1.35; (−8.58 to 11.29) 0.789
Int(11) 37.18 ± 12.29 45.80 ± 10.68 0.001 Int(9) 45.93 ± 9.14 43.27 ± 7.04 0.379
Handgrip affected
Con(11) 24.6 ± 5.9 25.5 ± 3.9 0.439 0.866 −0.905 (−3.935 to 2.125) 0.558 Con(10) 24.8 ± 3.47 21.55 ± 3.72 0.002 3.58; (1.50 to 5.67) 0.01a
Int (12) 25.1 ± 8.9 25.0 ± 7.4 0.969 Int(9) 24.39 ± 7.70 24.72 ± 8.72 0.525a
Handgrip non affected
Con (11) 25.5 ± 3.5 25.3 ± 3.9 0.768 0.481 1.583 (−0.666 to 3.833) 0.168 Con(9) 24.39 ± 2.95 24.06 ± 2.18 0.672 0.83; (−1.35 to 3.02) 0.455
Int (12) 23.8 ± 7.1 25.1 ± 6.9 0.085 Int(9) 23.22 ± 6.36 23.72 ± 7.04 0.526
Baseline (b) = 0
Δ = change, Gp Group, M ± SD Mean ± Standard Deviation, MD Mean Difference, CI Confidence Interval, n number, Con control group, Int intervention group
a non-parametric analysis
Loudon
et
al.BM
C
Com
plem
entary
and
A
lternative
M
edicine
 (2016) 16:343 
Page
10
of
15
Table 5 Results spinal mobility b-8 and 8b-12
Within group changes b-8 Between group changes b-8 Within group changes 8b-12 Between group changes 8b-12
VariableGp (n) Week 0
m ± SD
Week 8
m ± SD
P (0–8) P (0) Δint-Δcon 0–8
Md; (95 % CI)
P (0–8) Variable
Gp (n)
Week 8b
m ± SD
Week 12
m ± SD
P (8b-12) Δint-Δcon 8b-12
Md; (95 % CI)
P (8b-12)
LATERAL FLEXION
Pelvic Obliquity β1
Con(6) 15.40 ± 6.23 13.83 ± 6.09 0.585 0.007 −8.39; (−15.64 to −1.13) 0.023 Con(6) 13.83 ± 6.09 13.72 ± 8.79 0.972 0.52; (−8.29 to 9.33) 0.908
Int(9) 25.37 ± 6.90 15.41 ± 7.94 0.001 Int(7) 13.44 ± 5.58 13.84 ± 7.22 0.896
Lumbar range β2
Con(6) 24.82 ± 15.37 17.27 ± 9.12 0.016 0.521 6.48; (−1.43 to 14.40) 0.109 Con(6) 17.27 ± 9.12 19.33 ± 6.11 0.512 −5.54; (−13.96 to 2.88) 0.197
Int(9) 21.18 ± 10.35 20.11 ± 8.34 0.676 Int(7) 20.56 ± 9.12 17.09 ± 4.53 0.234
Thoracic range β3
Con(6) 48.80 ± 11.71 51.90 ± 3.14 0.286 0.543 0.72; (−6.63 to 8.08) 0.847 Con(6) 51.90 ± 3.14 55.63 ± 6.16 0.103 −2.91; (−9.02 to 3.21) 0.352
Int(9) 45.18 ± 14.55 49.00 ± 10.52 0.107 Int(7) 48.86 ± 9.31 49.69 ± 13.22 0.696
Shoulder range β4
Con(6) 92.08 ± 17.91 86.55 ± 11.96 0.151 0.962 3.21; (−6.55 to 12.97) 0.519 Con(6) 86.55 ± 11.96 87.77 ± 13.56 0.730 −2.06; (−11.47 to 7.35) 0.668
Int(9) 92.64 ± 25.78 90.32 ± 26.22 0.461 Int(7) 86.24 ± 26.01 85.40 ± 23.43 0.796
Thoracic distal curvature range βdc
Con(6) 47.83 ± 12.60 48.40 ± 6.16 0.920 0.518 6.50; (−7.70 to 20.70) 0.370 Con(6) 48.40 ± 6.16 43.42 ± 8.16 0.102 4.44; (−3.70 to 12.58) 0.285
Int(9) 43.72 ± 11.78 50.79 ± 14.59 0.123 Int(7) 50.99 ± 16.75 50.44 ± 17.53 0.847
Thoracic proximal curvature range βpc
Con(6) 29.62 ± 14.55 31.65 ± 9.83 0.663 0.898 −5.52; (−17.34 to 6.30) 0.360 Con(6) 31.65 ± 9.83 34.35 ± 13.48 0.408 −0.54; (−9.26 to 8.18) 0.903
Int(9) 30.66 ± 20.07 27.17 ± 13.23 0.360 Int(7) 26.20 ± 11.47 28.36 ± 10.77 0.475
Full lateral trunk inclination range βlti
Con(6) 60.12 ± 13.61 52.70 ± 7.60 0.024 0.505 −0.87; (−9.19 to 7.45) 0.837 Con(6) 52.70 ± 7.60 55.22 ± 10.16 0.406 −2.87; (−10.97 to 5.22) 0.486
Int(9) 65.07 ± 16.45 56.78 ± 14.88 0.002 Int(7) 55.47 ± 15.58 55.11 ± 12.13 0.899
FLEXION EXTENSION/ROTATION
Angle of thoracic kyphosis at rest αkrest
Con (6) 23.47 ± 8.68 25.80 ± 5.72 0.160 0.053 −3.88; (−8.08 to 0.32) 0.070 Con(6) 25.80 ± 5.72 21.57 ± 9.18 0.039 2.48; (−3.01 to 7.96) 0.376
Int (9) 31.60 ± 10.45 30.06 ± 7.86 0.254 Int(7) 30.69 ± 8.68 28.93 ± 10.85 0.355
Thoracic range α3
Con (6) 58.58 ± 10.03 58.63 ± 10.06 0.995 0.053 5.34; (−15.22 to 25.90) 0.611 Con(6) 58.63 ± 10.06 57.52 ± 14.28 0.873 3.95; (−14.73 to 22.62) 0.679
Int(9) 43.40 ± 16.90 48.79 ± 17.12 0.417 Int(7) 54.57 ± 14.38 57.40 ± 13.00 0.662
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Table 5 Results spinal mobility b-8 and 8b-12 (Continued)
Full trunk flexion/extension range αfti
Con(6) 163.78 ± 20.43 175.02 ± 1.88 0.016a .098a 7.48; (−31.00 to 45.95) 0.684a Con(6) 175.02 ± 1.88 166.88 ± 19.33 0.168 7.08; (−8.66 to 22.82) 0.378
Int(9) 135.93 ± 38.86 154.64 ± 30.64 0.125a Int(7) 151.56 ± 34.21 150.50 ± 39.95 0.846
Thoracic spinal rotation range Tr
Con(6) 84.23 ± 28.98 87.00 ± 20.01 0.764 0.171 8.28; (−15.05 to 31.60) 0.487 Con(6) 87.00 ± 20.01 93.62 ± 22.60 0.141 −7.79; (−19.79 to 4.21) 0.203
Int(9) 66.22 ± 28.33 77.27 ± 21.07 0.142 Int(7) 77.06 ± 13.80 75.88 ± 16.14 0.778
Baseline(b) = 0
Δ = change, Gp Group, M ± SD Mean ± Standard Deviation, MD Mean Difference, CI Confidence Interval, n number, Con control group, Int intervention group
a non-parametric analysis
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BCRL. The major finding was that pelvic obliquity was
reduced following the eight week yoga intervention. A
secondary finding was that strength was increased fol-
lowing the yoga intervention for shoulder abduction in
both the affected and non-affected arm.
There was noticeable lateral tilt of the pelvis (as mea-
sured by pelvic obliquity) for both the control and inter-
vention group at baseline indicating variation from ideal
posture. Changes in posture may be affected by a num-
ber of factors for this cohort including complications as-
sociated with BCRL. The one study on body posture of
those with BCRL [5] reported that participants displayed
mediolateral pelvic movement and dropped shoulder to
the affected side when walking. In addition faulty body
posture has been reported after breast cancer treatment
of mastectomy [31] a high risk factor for BCRL, indicat-
ing a forward leaning of the trunk and lack of symmetry
in the trunk and shoulders. These changes may be a re-
sult of the swelling, the different weight distribution of
the lymphoedematous limb and changed biomechanics
of the trunk and shoulder girdle from breast cancer
treatment, similar to what has been reported for those
with lower limb lymphoedema [32]. Nevertheless it must
be acknowledged that it is not uncommon for women in
this age group (median age 58) to have pelvic obliquity
from various age and life related stresses on the lower
body and pelvis including the effects of childbirth [33]
affecting postural alignment, pelvic stability, and walking
gait and hence the observed pelvic obliquity may not be
solely associated with BCRL.
The yoga intervention resulted in an improvement (re-
duction) in a static postural measure, the angle of pelvic
obliquity, between the groups (p = 0.023) due to an im-
provement in the yoga intervention group (p = 0.001). In
addition thoracic kyphosis, demonstrated a non-
significant improvement for the yoga group compared to
the control group (p = 0.07). While the intervention
group was outside the normative values for this measure
at baseline [30], there were no significant changes in ei-
ther group. While the differences between the groups at
baseline limit the ability to form conclusions about the
changes observed for this measure, changes in the angle
of kyphosis may need a longer intervention than the
current trial with reductions in kyphosis in one yoga
trial reported following three one hour yoga sessions per
week for 24 weeks [34]. Yoga focusses on teaching pos-
tural alignment from the feet through to the pelvis,
shoulders, neck and head before commencing any of the
physical, breathing or meditative practices. There is also
a strong focus on body awareness (kaya sthairyam). In
the current trial postural alignment and awareness were
taught before, during and after each practice in order to
create a stable foundation. Core stabilisation is also a
key feature of yoga and is achieved by engaging the
muscles of the transversus abdominis and pelvic floor
(moolabhanda) before engaging other muscles in many
yoga postures or as part of breathing practices. While
core strength was not measured in the current trial, the
improvement in pelvic obliquity indicated at least an
awareness of maintaining pelvic stability [15]. Pelvic sta-
bility while standing was improved following core stabil-
ity exercises [35] and in a Pilates intervention [36].
Although there were improvements in pelvic stability in
the intervention group it must be acknowledged that dif-
ferences existing at baseline meant that the potential for
improvement was high.
Strength in shoulder abduction improved in both arms
following the yoga intervention. However, these were
not significantly different to changes observed following
the control period, possibly due to the small sample size
in this pilot study. Nevertheless these results support
previous uncontrolled studies showing improvements in
handgrip strength following a yoga intervention [37] al-
though this was not supported by any improvements in
hand grip strength in the current study. The yoga inter-
vention had no weight-bearing on the arms; however,
the focus on stabilisation of the scapula/shoulder com-
plex (amsa bandha,) occurred for every action. Correct
scapula/shoulder stabilisation is dependent on space in
the sub-acromial area and scapulohumeral rhythm relies
on the correct firing of key stabilising muscles such as
the upper and lower trapezius, serratus anterior, pectoral
muscles and the rhomboids [38], which can be adversely
affected by breast cancer treatment [39]. Shoulder ab-
duction requires contraction of the supraspinatus and
deltoid muscles, which occurs in a fluid action when this
sub-acromial space exists. In the current trial, the focus
on shoulder stability may have led to improved scapulo-
humeral rhythm facilitating abduction strength. Another
trial based on gentle exercises, similar to the yoga inter-
vention, to achieve scapulohumeral control in a group of
participants with scapular dyskinesis (n = 18) showed
that specific gentle shoulder movements activated the
upper and lower trapezius and serratus anterior in both
groups [40]. We have previously reported reduced symp-
toms and tissue density in the upper arm and reduction
in fluid of the affected arm for the intervention group
[17]. It is likely that these improvements made the ac-
tion of abduction easier in the same way reduction of
fluid and improved postural alignment and stability im-
proved walking gait of those with lower limb lymhoe-
dema [32].
The intervention was not associated with increases in
ROM across any shoulder movement. The focus on cre-
ating stability of the glenohumeral complex may explain
the lack of increase in ROM. Similar studies involving
shoulder stability [41] or Pilates [36] also found no
changes in shoulder ROM. Interestingly, the Pilates
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intervention reported improved biomechanical control
of the scapula and trunk in lateral flexion [36], perhaps
indicating that stability is achieved prior to changes in
ROM. It is possible that the ROM results are due to a
learning effect from baseline to week eight as there was
a mean increase in 18 of the 20 measures of shoulder
ROM in both the intervention and control group over
this timeframe. The fact that this pattern did not con-
tinue from week 8 to 12 gives weight to this hypothesis.
While further study is required to determine the true ef-
fects of a yoga intervention on ROM in this population
the results highlight the potential importance of inclu-
sion of a familiarity phase prior to data collection in any
future study.
There were no significant between group changes in
spinal ROM. In comparison to norms for spinal mobility
[30], group mean baseline measurements revealed par-
ticipants in the current trial recorded lower flexion/ex-
tension and lateral flexion although they were within the
normal range for rotation. However, there was no
change in spinal mobility as a result of the yoga inter-
vention. Similar findings were observed following
12 weeks of Pilates [36] where it was suggested that par-
ticipants reduced compensatory movements of the spine
by focussing on segmental motion, postural alignment
and stability rather than on increasing their range. The
results of the current trial support this hypothesis.
As already acknowledged there are several limitations
in this study. These include the lack of familiarity testing
prior to data collection, the differences between the
groups in certain variables at baseline, as well as the
small sample size. Due to a lack of prior data to use to
calculate sample size, the a priori sample size calculation
performed for this study was based on clinically signifi-
cant changes in the major outcome variables with an as-
sumed level of variability [16]. This indicated that
between 13–19 participants would be required per group
and we proposed that 20 participants per group would
be recruited. Unfortunately we did not achieve the pro-
posed sample size and there was greater variability in
the results than anticipated resulting in wider confidence
intervals than expected. These factors impacted on the
statistical significance of results including potentially the
differences between the groups at baseline. Nevertheless
the pilot study results obtained provide important initial
data which will inform sample size calculations for any
future studies.
Conclusions
This pilot study highlights possible improvements in
posture evident in the reduction in the angle of pelvic
obliquity and trend to a reduced angle of kyphosis as a
result of the yoga intervention. Further, the intervention
group increased shoulder strength for both arms in the
action of abduction, an indicator that improved shoulder
stability may have occurred. The improvements ob-
served in this study may possibly be attributed to the
focus of the yoga intervention on overall placement of
body posture and function in each aspect of the yoga
during meditation, breathing, relaxation and execution
of the physical postures both moving and stationary.
Such increased awareness in body placement and
method of movement rather than a focus on increasing
flexibility of movement may account for the lack of
change in shoulder and spinal ROM. As women with
BCRL can experience problems with posture and shoul-
der actions these results possibly indicate that yoga may
offer some positive outcomes. While there are several
limitations including a small sample size, the data pro-
vides sufficient evidence of the potential benefits of yoga
to warrant larger controlled trials following the general
methodology outlined in this paper.
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